Clinical Trial Details
EORTC-06031
Back to Clinical Trials Database
Gemtuzumab ozogamicin (GO) monotherapy versus standard supportive care for previously untreated AML in elderly patients who are not eligible for intensive chemotherapy : a randomized phase II/III trial (AML-19) of the EORTC-LG and GIMEMA-ALWP.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 28-Jun-2004 Date Step1 close: 02-May-2013 |
Data management at EORTC | Yes |
Design |
Phase 2-3 Randomized open label |
Targeted Sample size | EORTC Groups: 75 - All Groups: 267 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00091234 |
NCT number | NCT00091234 |
EudraCT | 2004-004356-39 |